Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Levocetirizine in Infants with Allergic Rhinitis or Urticaria
NCT00628108Phase 3Completed
- Sponsor
- UCB
- Start
- Mar 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levocetirizine in allergic rhinitis (AR), chronic idiopathic urticaria (CIU), sponsored by UCB. Started Mar 2008; status: completed.
02
Drugs
levocetirizine
03
Conditions
allergic rhinitis (AR)chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on NCT00628108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00628108.